Skip to content
Aperlena
Free alerts

Spain - Pharmaceutical products - Supply of exclusive Lilly S.A. medicines to be awarded by negotiated procedure without publication

Original España - Productos farmacéuticos - Suministro de medicamentos exclusivos de Lilly S.A. a adjudicar por procedimiento negociado sin publicidad.

Awarded Contract award

Key facts

Winner
Lilly, S.A.
Awarded value
€225,572
Buyer
Hospital Universitario Fundación Alcorcón
Where
Spain Comunidad de Madrid
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
586143-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Summary

Machine-generated summary

Hospital Universitario Fundación Alcorcón in Spain awarded a negotiated procedure without publication contract for the supply of medicines with exclusive distribution by Lilly S.A. The products include Omvoh (mirikizumab) in injectable pen and infusion solution presentations and Cyramza (ramucirumab) as infusion concentrate. The contract was won by Lilly, S.A. for EUR 225,572.02. The awarded price is the same as the estimated value within 1%.

Description

Suministro de medicamentos de distribución exclusiva de Lilly S.A Omvoh 100 mg solución inyectable en pluma precargada + Omvoh 200 mg solución inyectable en pluma precargada, 1 pluma precargada de 100 mg + 1 pluma precargada de 200 mg Principio activo: Mirikizumab; Omvoh 200 mg solución inyectable en pluma precargada, 1 pluma precargada de 2 ml Principio activo: Mirikizumab; Omvoh 300 mg concentrado para solución para perfusión, 1 vial de 15 ml Principio activo: Mirikizumab; Cyramza 10 mg/ml concentrado para solución para perfusión 100mg Principio activo: Ramucirumab; Cyramza 10 mg/ml concentrado para solución para perfusión 500 mg Principio activo: Ramucirumab

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

2 open tenders right now

Recent awards

Similar tenders

1

day left

Supply of hygiene material

Spain Medical equipment & pharmaceuticals TGSS-Dirección provincial de Álava

€13,972

est. value

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,376,946
9,813 open across Europe right now 98% below sector average
Buyer track record on Aperlena
66 notices tracked · 37 awarded
€32,604,694 in awarded contracts

Never miss a tender like this

941 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language